Understanding the Business Case for Phage Therapy
Note: This description is sourced from the original post. We recommend reading the full post on the event site.
Join us in our fourth 2025 panel discussion on “𝗨𝗻𝗱𝗲𝗿𝘀𝘁𝗮𝗻𝗱𝗶𝗻𝗴 𝘁𝗵𝗲 𝗕𝘂𝘀𝗶𝗻𝗲𝘀𝘀 𝗖𝗮𝘀𝗲 𝗳𝗼𝗿 𝗣𝗵𝗮𝗴𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆,” as part of our 𝗔𝗻𝘁𝗶𝗺𝗶𝗰𝗿𝗼𝗯𝗶𝗮𝗹 𝗥𝗲𝘀𝗶𝘀𝘁𝗮𝗻𝗰𝗲 (𝗔𝗠𝗥) and 𝗣𝗵𝗮𝗴𝗲 𝗧𝗵𝗲𝗿𝗮𝗽𝘆 series.In this event, we will explore the economic viability, market potential, and strategic pathways for the successful commercialization of phage therapy.Our feature panelist is Mayukh Das, Chief Operating Officer (COO), Phiogen.
Date
17 September 2025
Time
19.30 CET
Location
Online
Organizer
Phage Hunters Training and Research Program